Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer.
Jana IvanidzeKritika SubramanianTrisha YounTessa CiglerJoseph R OsborneRajiv S MaggeOnyinye D BalogunJonathan P S KniselyRohan RamakrishnaPublished in: Neuro-oncology advances (2021)
Keyphrases
- pet ct
- estrogen receptor
- brain metastases
- positive breast cancer
- small cell lung cancer
- resting state
- white matter
- positron emission tomography
- contrast enhanced
- functional connectivity
- cerebral ischemia
- magnetic resonance imaging
- multiple sclerosis
- magnetic resonance
- computed tomography
- blood brain barrier
- subarachnoid hemorrhage